Virus News and Research

Latest Virus News and Research

Air purification technologies to combat SARS-CoV-2

The onset of the COVID-19 pandemic had people sharing an array of strategies for disinfection and disease prevention.

17 Mar 2021

Researchers develop rapid method for identifying antibody-resistant SARS-CoV-2 mutants

Researchers in the United States have described a novel rapid method for identifying antibody-resistant mutants in SARS-CoV-2.

17 Mar 2021

Could visible light be a safe and effective SARS-CoV-2 disinfectant?

A new study reports that blue light with a wavelength of 400–420 nm can inactivate enveloped viruses like SARS-CoV-2 and influenza. This could allow continuous disinfection of spaces even when people are present.

17 Mar 2021

Two mouthwashes disrupt COVID-19 virus under laboratory conditions

Researchers at Rutgers School of Dental Medicine have found evidence that two types of mouthwash disrupt the COVID-19 virus under laboratory conditions, preventing it from replicating in a human cell.

17 Mar 2021

Can vaccination and infection rates add up to reach Covid herd immunity?

It's been a long, dark winter of Covid concerns, stoked by high post-holiday case counts and the American death tally exceeding 530,000 lives lost.

17 Mar 2021

Quantum dot-based affinity biosensors in microfluidic systems offer an alternative SARS-CoV-2 diagnostics platform

In a new study published in Emergent Materials, researchers show how microfluidic systems integrated with quantum dot-based affinity biosensors can serve as a valuable platform to rapidly and accurately diagnose SARS-CoV-2 infection.

17 Mar 2021

How can a rapid COVID-19 vaccine rollout expedite the relaxation of pandemic restrictions?

A new study describes a model in which NPIs can be safely relaxed while vaccination is still ongoing, with emphasis on the speed of vaccination campaigns.

17 Mar 2021

Researchers explore difference in reactions to SARS-CoV-2 infection between children and adults

The COVID-19 pandemic has claimed over 2.67 million lives in less than a year and a half. However, it is uncommon in children, with less than 2% of the cases being in individuals below the age of 19. Most of these are of mild severity, with the clinical features of severe COVID-19 being rare in this age group.

17 Mar 2021

Socioeconomic disparities could explain the association of race/ethnicity with worse COVID-19 outcomes

A new study published online in the Annals of the American Thoracic Society reveals how socioeconomic factors partially explain the increased odds that Black and Hispanic Americans have of testing positive for SARS-CoV-2, the virus that causes COVID-19.

17 Mar 2021

New research proposes innovative antibody-based treatment to prevent SARS-CoV-2 viral entry

A brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy to inhibit the ability of SARS-CoV-2 to invade human cells.

17 Mar 2021

Researchers develop innovative profiling methods for SARS-CoV-2 infection

A team of researchers from various institutions in the USA used RNA-sequencing data and other methods to profile unique genes and other characteristics associated with SARS-CoV-2 in New York City (NYC).

17 Mar 2021

COVID-19 has increased stress levels in the U.S pregnant women

COVID-19 has created new problems for pregnant women in the United States, a group that already faced the highest maternal mortality rate in the developed world even before the pandemic.

17 Mar 2021

Abbott Pandemic Defence Coalition aims to identify new viral threats and take quick action

Abbott today announced the formation of the Abbott Pandemic Defence Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.

17 Mar 2021

Compromised immunity can allow SARS-CoV-2 to evade the immune system

The vast majority of people infected with SARS-CoV-2 clear the virus, but those with compromised immunity--such as individuals receiving immune-suppressive drugs for autoimmune diseases--can become chronically infected.

17 Mar 2021

Living with a COVID-19 case brings worse symptoms and stronger antibody response

This study suggests that high virus exposure levels contribute to greater disease severity and stronger antibody responses. The observations from this study are published on the medRxiv preprint server.

17 Mar 2021

People with high BMI may now receive their COVID-19 vaccine in California

Now, California state allows individuals with one of ten comorbidities to get their COVID-19 jabs. This comes after obesity being tagged as COVID-19 vaccine eligibility.

16 Mar 2021

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

As vaccine efforts against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease, roll out in various countries, Moderna ups the game by testing its next-generation COVID-19 vaccine.

16 Mar 2021

Salivary IgG to SARS-CoV-2 after mild COVID-19

A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have antibodies for the disease up to nine months after acquiring the disease, even if they displayed only mild symptoms.

16 Mar 2021

New Colombian SARS-CoV-2 lineage shares antibody-resistant mutations with other variants

Scientists in Colombia have identified a new highly divergent SARS-CoV-2 lineage with Spike substitutions L249S and E484K. These same mutations have convergently appeared in other mutant strains of the virus, most notably in variants of concern.

16 Mar 2021

SARS-CoV-2 can spread through cold-chain transport

In light of growing evidence, researchers say that SARS-CoV-2 virus transmission via contaminated surfaces, and in particular, frozen foods and products that are transported while keeping them at low temperatures, should be taken into account when devising prevention strategies.

16 Mar 2021

Virus News and Research

Latest Virus News and Research

Air purification technologies to combat SARS-CoV-2

Researchers develop rapid method for identifying antibody-resistant SARS-CoV-2 mutants

Could visible light be a safe and effective SARS-CoV-2 disinfectant?

Two mouthwashes disrupt COVID-19 virus under laboratory conditions

Can vaccination and infection rates add up to reach Covid herd immunity?

Quantum dot-based affinity biosensors in microfluidic systems offer an alternative SARS-CoV-2 diagnostics platform

How can a rapid COVID-19 vaccine rollout expedite the relaxation of pandemic restrictions?

Researchers explore difference in reactions to SARS-CoV-2 infection between children and adults

Socioeconomic disparities could explain the association of race/ethnicity with worse COVID-19 outcomes

New research proposes innovative antibody-based treatment to prevent SARS-CoV-2 viral entry

Researchers develop innovative profiling methods for SARS-CoV-2 infection

COVID-19 has increased stress levels in the U.S pregnant women

Abbott Pandemic Defence Coalition aims to identify new viral threats and take quick action

Compromised immunity can allow SARS-CoV-2 to evade the immune system

Living with a COVID-19 case brings worse symptoms and stronger antibody response

People with high BMI may now receive their COVID-19 vaccine in California

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

Salivary IgG to SARS-CoV-2 after mild COVID-19

New Colombian SARS-CoV-2 lineage shares antibody-resistant mutations with other variants

SARS-CoV-2 can spread through cold-chain transport

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in